MUC20 and Miyoshi myopathy: In addition, MUC20 expression in the CD138 + bone marrow plasma cells of patients with PI-sensitive MM (tMM) receiving initial therapy with BTZ, thalidomide, and dexamethasone (VTD) (GSE31504) was higher than that in HDs and patients with MGUS MM, SMM, and NDMM (Fig. 1D).